Article Information
History
- December 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sivaraj M. Sundaram1,
- Adriana Arrulo Pereira1,
- Hannes Köpke1,
- Helge Müller-Fielitz1,
- Meri De Angelis2,
- Timo D. Müller2,
- Heike Heuer3,
- Jakob Körbelin1,4,
- Markus Krohn1,
- Jens Mittag5,
- Ruben Nogueiras6,
- Vincent Prevot7 and
- Markus Schwaninger1,8,*
- 1Institute for Experimental and Clinical Pharmacology and Toxicology, Center of Brain, Behavior and Metabolism, University of Lübeck, Lübeck, Germany
- 2Institute for Diabetes and Obesity, Helmholtz Zentrum Munich, Munich, and German Center for Diabetes Research (DZD), Germany
- 3Department of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University Duisburg-Essen, Essen, Germany
- 4Department of Oncology, Hematology and Bone Marrow Transplantation, UKE Hamburg-Eppendorf, Hamburg, Germany
- 5Institute for Endocrinology and Diabetes, Center of Brain, Behavior and Metabolism, University of Lübeck, Lübeck, Germany
- 6Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- 7Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, European Genomic Institute for Diabetes (EGID), Lille, France
- 8DZHK (German Research Centre for Cardiovascular Research), Hamburg-Lübeck-Kiel, Germany
- ↵*Address correspondence to: Markus Schwaninger, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany, Phone: +49-451-31017200, E-Mail: markus.schwaninger{at}uni-luebeck.de